Dexcom EVP sells $143K in stock under 10b5-1 plan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
DEXCOM INC (DXCM) executive Michael Jon Brown, EVP and Chief Legal Compliance Officer, reported selling 1,700 shares of common stock on September 15, 2026 at $84.04 per share in an open-market or private transaction made pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2025.
Following this sale, Brown directly holds 99,885 shares, which includes 71,903 unvested restricted stock units scheduled to vest between March 8, 2027 and March 8, 2029, and 83 shares acquired under Dexcom’s Amended and Restated 2015 Employee Stock Purchase Plan.
Insider Trade Summary 10b5-1
Net Seller: 1,700 shares
Net Sell
1 txn
Insider
Brown Michael Jon
Role
EVP Chief Legal Compliance Off
Sold
1,700 shs ($143K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,700 | $84.04 | $143K |
Holdings After Transaction:
Common Stock — 99,885 shares (Direct)
Footnotes (2)
- F1. On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan.
- F2. Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.
Key Figures
Shares sold: 1,700 shares
Sale price per share: $84.04 per share
Implied transaction value: $142,868
+3 more
6 metrics
Shares sold
1,700 shares
Non-derivative sale on September 15, 2026 by EVP and Chief Legal Compliance Officer
Sale price per share
$84.04 per share
Price for the 1,700 Dexcom common shares sold on September 15, 2026
Implied transaction value
$142,868
1,700 shares sold at $84.04 per share
Shares held after transaction
99,885 shares
Direct Dexcom common stock holdings of Michael Jon Brown after the sale
Unvested restricted stock units
71,903 RSUs
Unvested RSUs included in Brown’s post-transaction holdings, vesting through March 8, 2029
ESPP shares held
83 shares
Shares acquired under Dexcom’s Amended and Restated 2015 Employee Stock Purchase Plan
Key Terms
Rule 10b5-1 Plan, restricted stock units, Employee Stock Purchase Plan
3 terms
Rule 10b5-1 Plan regulatory
"Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
restricted stock units financial
"Included in this number are 71,903 unvested restricted stock units, 39,019 of which"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Dexcom (DXCM) report for Michael Jon Brown?
Dexcom reported that Michael Jon Brown, EVP and Chief Legal Compliance Officer, sold 1,700 shares of common stock on September 15, 2026 at $84.04 per share in a sale classified as an open-market or private transaction.
Was the DXCM insider sale made under a Rule 10b5-1 trading plan?
Yes. The filing states that Brown adopted a Rule 10b5-1 Plan on November 26, 2025, which allows orderly disposition of his shares, and that the 1,700 shares sold on September 15, 2026 were sold pursuant to this 10b5-1 Plan.
What unvested RSUs does Michael Jon Brown have in Dexcom (DXCM)?
Brown’s post-transaction holdings include 71,903 unvested restricted stock units, consisting of grants made on March 8, 2026, March 8, 2025, and March 8, 2024, scheduled to vest through March 8, 2029 according to the detailed vesting schedule.
What portion of Michael Jon Brown’s Dexcom (DXCM) holdings comes from the employee stock purchase plan?
Within Brown’s 99,885 shares of Dexcom common stock held after the sale, the filing specifies that 83 shares were acquired under Dexcom’s Amended and Restated 2015 Employee Stock Purchase Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
